Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vance G Fowler

Showing results (411-420 of 426) with videos related to

Pageof 43
Sort By:
Frontiers in Microbiology|June 30, 2020
The Diversity of Lipopolysaccharide (O) and Capsular Polysaccharide (K) Antigens of Invasive <i>Klebsiella pneumoniae</i> in a Multi-Country CollectionMyeongjin Choi, Nicolas Hegerle, Joseph Nkeze, et al.
Plos Genetics|October 6, 2018
Human genetic variation in GLS2 is associated with development of complicated Staphylococcus aureus bacteremiaWilliam K Scott, Felix Mba Medie, Felicia Ruffin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 8, 2026
Escherichia coli ST131 Drives Carbapenem Use for E. Coli Bloodstream InfectionsNatalie A Mackow, Wanying Shao, Lizhao Ge, et al.
Antimicrobial Agents and Chemotherapy|May 15, 2026
Resistance to novel β-lactam/β-lactamase inhibitors among carbapenem-resistant <i>Pseudomonas aeruginosa</i> and clinical implications in the prospective observational <i>Pseudomonas</i> studyLee S Gottesdiener, Yixuan Li, Kerryl E Greenwood-Quaintance, et al.
The Lancet. Infectious Diseases|March 11, 2020
Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort studyDavid van Duin, Cesar A Arias, Lauren Komarow, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 22, 2023
Clinical Outcomes and Bacterial Characteristics of Carbapenem-resistant Acinetobacter baumannii Among Patients From Different Global RegionsMinggui Wang, Lizhao Ge, Liang Chen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 10, 2023
Plasma Microbial Cell-Free DNA Sequencing in Immunocompromised Patients With Pneumonia: A Prospective Observational StudyStephen P Bergin, Roy F Chemaly, Sanjeet S Dadwal, et al.
The Lancet. Infectious Diseases|November 12, 2021
Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort studyMinggui Wang, Michelle Earley, Liang Chen, et al.
The Lancet. Microbe|February 12, 2023
Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort studyJinnethe Reyes, Lauren Komarow, Liang Chen, et al.
Open Forum Infectious Diseases|August 2, 2024
Clinical Utility of Plasma Microbial Cell-Free DNA Sequencing Among Immunocompromised Patients With PneumoniaDeng B Madut, Roy F Chemaly, Sanjeet S Dadwal, et al.
Pageof 43

Showing results (411-420 of 426) with videos related to

Sort By:
Pageof 43
Frontiers in Microbiology|June 30, 2020
The Diversity of Lipopolysaccharide (O) and Capsular Polysaccharide (K) Antigens of Invasive <i>Klebsiella pneumoniae</i> in a Multi-Country CollectionMyeongjin Choi, Nicolas Hegerle, Joseph Nkeze, et al.
Plos Genetics|October 6, 2018
Human genetic variation in GLS2 is associated with development of complicated Staphylococcus aureus bacteremiaWilliam K Scott, Felix Mba Medie, Felicia Ruffin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 8, 2026
Escherichia coli ST131 Drives Carbapenem Use for E. Coli Bloodstream InfectionsNatalie A Mackow, Wanying Shao, Lizhao Ge, et al.
Antimicrobial Agents and Chemotherapy|May 15, 2026
Resistance to novel β-lactam/β-lactamase inhibitors among carbapenem-resistant <i>Pseudomonas aeruginosa</i> and clinical implications in the prospective observational <i>Pseudomonas</i> studyLee S Gottesdiener, Yixuan Li, Kerryl E Greenwood-Quaintance, et al.
The Lancet. Infectious Diseases|March 11, 2020
Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort studyDavid van Duin, Cesar A Arias, Lauren Komarow, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 22, 2023
Clinical Outcomes and Bacterial Characteristics of Carbapenem-resistant Acinetobacter baumannii Among Patients From Different Global RegionsMinggui Wang, Lizhao Ge, Liang Chen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 10, 2023
Plasma Microbial Cell-Free DNA Sequencing in Immunocompromised Patients With Pneumonia: A Prospective Observational StudyStephen P Bergin, Roy F Chemaly, Sanjeet S Dadwal, et al.
The Lancet. Infectious Diseases|November 12, 2021
Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort studyMinggui Wang, Michelle Earley, Liang Chen, et al.
The Lancet. Microbe|February 12, 2023
Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort studyJinnethe Reyes, Lauren Komarow, Liang Chen, et al.
Open Forum Infectious Diseases|August 2, 2024
Clinical Utility of Plasma Microbial Cell-Free DNA Sequencing Among Immunocompromised Patients With PneumoniaDeng B Madut, Roy F Chemaly, Sanjeet S Dadwal, et al.
Pageof 43